The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Strongyloides hyperinfection syndrome: an emerging global infectious disease
Abstract
The hyperinfection syndrome (HS) caused by Strongyloides stercoralis has a high mortality rate (15% to 87%). A variety of risk factors and predisposing conditions have been described, including new immunosuppressive therapies; HTLV-1 infection; cadaveric transplantation; immune reconstitution syndrome; haematological malignancies (especially lymphoma); tuberculosis; malnutrition secondary to chronic Strongyloides diarrhoea; international travel and immigration. Inhibition of Th2 cell-mediated, humoral or mucosal immunity is associated with HS. HS is more frequently seen in HTLV-1 than HIV patients. In AIDS, there is an increase in Th2 cytokines, while in HTLV-1 infection there is a decrease in the Th2 response, leading to an increased risk of autoinfection. Corticosteroid use remains the most frequent risk factor for HS. A number of ELISAs are useful for diagnosis and post-treatment evaluation. Once diagnosed, the disease may be managed effectively with anthelminthic drugs, including ivermectin. HS causes diverse symptoms and signs, with unusual manifestations leading to misdiagnosis and medical errors related to healthcare providers' lack of familiarity with the condition. HS is an example of an emerging tropical infection migrating to developed countries and requiring greater clinician awareness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of Strongyloides stercoralis Infection
Siddiqui, A. A., & Berk, S. L. (2001) · Clinical Infectious Diseases · doi:10.1086/322707 · Cited by 866
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
Verdonck, K., González, E., Van Dooren, S., Vandamme, A.-M., Vanham, G., & Gotuzzo, E. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70081-6 · Cited by 661
Self-citationSebus, J., Er, C., & Ja, V. D. B. (1964) · PubMed · Cited by 463
Genta, R. M. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.5.755 · Cited by 384
Intestinal strongyloidiasis and hyperinfection syndrome
Vadlamudi, R., Chi, D. S., & Krishnaswamy, G. A. (2006) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-4-8 · Cited by 268
Intestinal Strongyloidiasis: Recognition, Management, and Determinants of Outcome
Concha, R., Harrington, W., & Rogers, A. I. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000152779.68900.33 · Cited by 228
Epidemiological and clinical interaction between HTLV‐1 and Strongyloides stercoralis
Carvalho, E. M., & Da Fonseca Porto, A. (2004) · Parasite Immunology · doi:10.1111/j.0141-9838.2004.00726.x · Cited by 218
van Doorn, H. R., Koelewijn, R., Hofwegen, H., Gilis, H., Wetsteyn, J. C. F. M., Wismans, P. J., Sarfati, C., Vervoort, T., & van Gool, T. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01735-06 · Cited by 147
Barker, E., Mackewicz, C. E., & Levy, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11135 · Cited by 135
Cytokines and cytokine therapies in HIV infection.
Valdez, H., & Lederman, M. M. (1997) · PubMed · Cited by 126
Hirata, T., Uchima, N., Kishimoto, K., Zaha, O., Kinjo, N., Hokama, A., Sakugawa, H., Kinjo, F., & Fujita, J. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.246 · Cited by 122
Marty, F. M., Lowry, C. M., Rodriguez, M., Milner, D. A., Pieciak, W., Sinha, A., Fleckenstein, L. L., & Baden, L. R. (2005) · Clinical Infectious Diseases · doi:10.1086/430827 · Cited by 106
Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy
Page, W. A., Dempsey, K., & McCarthy, J. S. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.12.006 · Cited by 89
Strongyloidiasis in Patients with Hematologic Malignancies
Nucci, M., Portugal, R. D., Pulcheri, W., Spector, N., Ferreira, S. B., de Castro, M. B., Noe, R., & de Oliveira, H. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.675 · Cited by 81
Culshaw, R. J., Bancroft, G. J., & McDonald, V. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3074-3079.1997 · Cited by 80
Satoh, M., Toma, H., Sato, Y., Takara, M., Shiroma, Y., Kiyuna, S., & Hirayama, K. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01733.x · Cited by 76
Pacanowski, J., Santos, M. D., Roux, A., Maignan, C. L., Guillot, J., Lavarde, V., & Cornet, M. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.122 · Cited by 64
Imported Strongyloidosis: A Longitudinal Analysis of 31 Cases
Nüesch, R., Zimmerli, L., Stöckli, R., Gyr, N. E., & Hatz, F. R. C. (2006) · Journal of Travel Medicine · doi:10.2310/7060.2005.12204 · Cited by 58
Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection
Terashima, A., Bianchi, H. A., Tello, R., Infante, R. M., Freedman, D. O., & Gotuzzo, E. (2002) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(02)90132-3 · Cited by 56
Self-citationBrown, M. M., Cartledge, J. D., & Miller, R. F. (2006) · International Journal of STD & AIDS · doi:10.1258/095646206778145712 · Cited by 50
Tanaka, M., Hirabayashi, Gatanaga, Aizawa, Hachiya, Takahashi, Y., TASHIRO, T., Kohsaka, Oyamada, Ida, et al. (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00627.x · Cited by 49
CELLULAR EFFECTS OF GLUCOCORTICOIDS
Corrigan, C. J. (1999) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(05)70116-8 · Cited by 9
García‐Marcos, L., Terashima, A., Samalvides, F., Alvarez, H., Lindo, F., Tello, R., Canales, M., Demarini, J., & Gotuzzo, E. (2006) · PubMed · Cited by 9
Self-citation
Cited by
Strongyloides stercoralis: Global Distribution and Risk Factors
Schär, F., Trostdorf, U., Giardina, F., Khieu, V., Muth, S., Marti, H., Vounatsou, P., & Odermatt, P. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002288 · Cited by 739
Strongyloidiasis – the most neglected of the neglected tropical diseases?
Olsen, A., van Lieshout, L., Marti, H., Polderman, T., Polman, K., Steinmann, P., Stothard, R., Thybo, S., Verweij, J. J., & Magnussen, P. (2009) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2009.02.013 · Cited by 579
A Research Agenda for Helminth Diseases of Humans: The Problem of Helminthiases
Lustigman, S., Prichard, R. K., Gazzinelli, A., Grant, W. N., Boatin, B. A., McCarthy, J. S., & Basáñez, M.-G. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001582 · Cited by 339
Ye, L., Taylor, G. P., & Rosadas, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.832430 · Cited by 36
Talukder, M. R., Pham, H., Woodman, R., Wilson, K., Taylor, K., Kaldor, J., & Einsiedel, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042084 · Cited by 11
Metadata
- Authors
- Marcos, L. A., Terashima, A., DuPont, H. L., & Gotuzzo, E.
- Venue
- Transactions of the Royal Society of Tropical Medicine and Hygiene
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04
- Volume
- 102
- Issue
- 4
- Pages
- 314-318
- ISSN
- 0035-9203 (ISSN-L)
- OpenAlex
- W2036253433
- Cited by
- 324
- References
- 23
- FWCI
- 16.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.